Полина Домбуре, директор Inpharmatis, приняла участие в ISPE Europe Annual Conference 2024
April 23, 2024
January 15, 2021
Are You Ready for 2021 EAEU Regulatory Changes?
Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).
For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.
If you want to find out more information about EAEU registration rules, please contact us at info@inpharmatis.com.
Dr. Polina Dombure, Inpharmatis Group CEO, Participated in ISPE Europe Annual Conference 2024
April 23, 2024
Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024
Challenges of Medical Devices Registration in the EAEU
March 26, 2024
Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024
New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024
В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024
In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks
February 28, 2024
Получение GMP сертификата ЕАЭС обязательная процедура
February 21, 2024
EAEU GMP Certificate is Mandatory
February 20, 2024